| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
L | | FI | PI | | Zofran 4 mg/2 mL | 5 x 2 ml | 41.61 | 61.00 | 40% | | Infusionskonzentrat: Ondansetronum 4mg / 2ml | Sandoz Pharmaceuticals AG | B / SL / SO | FB | | G |  |
L | | FI | PI | | Zofran 4 mg/2 mL | 10 x 2 ml | 83.22 | 105.60 | 40% | | Infusionskonzentrat: Ondansetronum 4mg / 2ml | Sandoz Pharmaceuticals AG | B / SL / SO | FB | | G |  |
L | | FI | PI | | Zofran 8 mg/4 mL | 5 x 4 ml | 76.73 | 98.70 | 40% | | Infusionskonzentrat: Ondansetronum 8mg / 4ml | Sandoz Pharmaceuticals AG | B / SL / SO | FB | | G |  |
L | | FI | PI | | Zofran 8 mg/4 mL | 8 x 4 ml | 122.77 | 148.05 | 40% | | Infusionskonzentrat: Ondansetronum 8mg / 4ml | Sandoz Pharmaceuticals AG | B / SL / SO | FB | | G |  |
L | | FI | PI | | Zofran 4 mg | 10 Tablette(n) | 26.59 | 45.05 | 40% | | Filmtabletten: Ondansetronum 4 mg | Sandoz Pharmaceuticals AG | B / SL / SO | FB | | G |  |
L | | FI | PI | | Zofran 8 mg | 6 Tablette(n) | 26.68 | 45.10 | 40% | | Filmtabletten: Ondansetronum 8 mg | Sandoz Pharmaceuticals AG | B / SL / SO | FB | | G |  |
L | | FI | PI | | Zofran Zydis 4 mg - T | 10 Tablette(n) | 26.59 | 45.05 | 40% | | Zydis Lingualtabletten: Ondansetronum 4 mg | Sandoz Pharmaceuticals AG | B / SL / SO | FB | | G |  |
L | | FI | PI | | Zofran Zydis 8 mg ‐ F - T | 6 Tablette(n) | 26.68 | 45.10 | 40% | | Zydis Lingualtabletten: Ondansetronum 8 mg | Sandoz Pharmaceuticals AG | B / SL / SO | FB | | G |  |
L | | FI | PI | | Ondansetron ODT Labatec 4 mg | 10 Tablette(n) | 22.60 | 40.95 | 10% | | Schmelztabletten: Ondansetronum 4 mg | Labatec Pharma SA | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ondansetron ODT Labatec 8 mg | 6 Tablette(n) | 22.61 | 40.95 | 10% | | Schmelztabletten: Ondansetronum 8 mg | Labatec Pharma SA | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Ondansetron ODT Sandoz 4 mg | 10 | 22.60 | 40.95 | 10% | | Schmelztabletten: Ondansetronum 4 mg | Sandoz Pharmaceuticals AG | ● B / SL / SG | FB | | G |  |
L | | FI | | CM | Ondansetron ODT Sandoz 8 mg | 6 | 22.61 | 40.95 | 10% | | Schmelztabletten: Ondansetronum 8 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ondansetron-Teva 4 oro | 10 Tablette(n) | 22.60 | 40.95 | 10% | | Schmelztabletten: Ondansetronum 4 mg | Teva Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ondansetron-Teva 8 oro | 6 Tablette(n) | 22.61 | 40.95 | 10% | | Schmelztabletten: Ondansetronum 8 mg | Teva Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ondansetron Accord 8 mg/4 ml | 5 | 57.55 | 79.00 | 10% | | Infusionskonzentrat: Ondansetronum 8mg / 4ml | Accord Healthcare AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ondansetron Fresenius i.v. 4 mg/2 ml | 5 1 Ampulle(n) à 2 ml | 30.91 | 50.05 | 10% | | Infusionskonzentrat: Ondansetronum 4mg / 2ml | Fresenius Kabi (Schweiz) AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ondansetron Fresenius i.v. 8 mg/4 ml | 5 1 Ampulle(n) à 4 ml | 57.55 | 79.00 | 10% | | Infusionskonzentrat: Ondansetronum 8mg / 4ml | Fresenius Kabi (Schweiz) AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ondansetron Labatec, 4mg/2ml | 5 1 Ampulle(n) à 2 ml | 30.90 | 50.00 | 10% | | Infusionskonzentrat: Ondansetronum 4mg / 2ml | Labatec Pharma SA | B / SL / SG | FB | | G |  |
L | | FI | | | Ondansetron Labatec, 8mg/4ml | 5 1 Ampulle(n) à 4 ml | 57.55 | 79.00 | 10% | | Infusionskonzentrat: Ondansetronum 8mg / 4ml | Labatec Pharma SA | B / SL / SG | FB | | G |  |
L | | FI | | | Ondansetron-Teva 4mg/2ml | 5 x 2 ml | 30.86 | 50.00 | 10% | | Infusionskonzentrat: Ondansetronum 4mg / 2ml | Teva Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ondansetron-Teva 8mg/4ml | 5 x 4 ml | 57.55 | 79.00 | 10% | | Infusionskonzentrat: Ondansetronum 8mg / 4ml | Teva Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ondansetron Labatec 4 mg | 10 Tablette(n) | 20.56 | 38.85 | 10% | | Filmtabletten: Ondansetronum 4 mg | Labatec Pharma SA | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ondansetron Labatec 8 mg | 6 Tablette(n) | 20.56 | 38.85 | 10% | | Filmtabletten: Ondansetronum 8 mg | Labatec Pharma SA | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Ondansetron Sandoz 4 mg | 10 | 20.56 | 38.85 | 10% | | Filmtabletten: Ondansetronum 4 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | | CM | Ondansetron Sandoz 8 mg | 6 | 20.56 | 38.85 | 10% | | Filmtabletten: Ondansetronum 8 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ondansetron-Teva, 4 mg | 10 Tablette(n) | 20.56 | 38.85 | 10% | | Filmtabletten: Ondansetronum 4 mg | Teva Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ondansetron-Teva, 8 mg | 6 Tablette(n) | 20.56 | 38.85 | 10% | | Filmtabletten: Ondansetronum 8 mg | Teva Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | | CM | Ondansetron Sandoz 4 mg/2 ml | 5 x 2 ml | 30.88 | 50.00 | 10% | | Infusionskonzentrat/ Injektionslösung: Ondansetronum 4mg / 2ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | | CM | Ondansetron Sandoz 4 mg/2 ml | 10 x 2 ml | 61.76 | 83.60 | 10% | | Infusionskonzentrat/ Injektionslösung: Ondansetronum 4mg / 2ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | | CM | Ondansetron Sandoz 8 mg/4 ml | 5 x 4 ml | 57.55 | 79.00 | 10% | | Infusionskonzentrat/ Injektionslösung: Ondansetronum 8mg / 4ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | | CM | Ondansetron Sandoz 8 mg/4 ml | 8 x 4 ml | 92.08 | 116.55 | 10% | | Infusionskonzentrat/ Injektionslösung: Ondansetronum 8mg / 4ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | | | Ondansetron Accord 4 mg/2 ml | 5 | 30.88 | 50.00 | 10% | | Konzentrat zur Herstellung einer Infusionslösung / Injektionslösung: Ondansetronum 4mg / 2ml | Accord Healthcare AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Ondansetron ODT Labatec 4 mg | 6 Tablette(n) | PA | PA | k.A. | | Schmelztabletten: Ondansetronum 4 mg | Labatec Pharma SA | B | FB | | G |  |
| | FI | PI | | Ondansetron ODT Labatec 8 mg | 10 Tablette(n) | PA | PA | k.A. | | Schmelztabletten: Ondansetronum 8 mg | Labatec Pharma SA | B | FB | | G |  |
| | FI | PI | | Ondansetron Labatec 8 mg | 10 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Ondansetronum 8 mg | Labatec Pharma SA | B | FB | | G |  |
|
L | | FI | | | Kytril, Konzentrat zur Herstellung einer Infusionslösung 3 mg | 5 Ampulle(n) | 78.43 | 101.00 | 10% | | Granisetronum 3mg / 3ml | Atnahs Pharma Switzerland AG | B / SL / SO | FB | | G |  |
L | | FI | | | Kytril, Konzentrat zur Herstellung einer Infusionslösung 1 mg | 5 Ampulle(n) | 34.05 | 53.15 | 10% | | Granisetronum 1 mg/ml | Atnahs Pharma Switzerland AG | B / SL / SO | FB | | G |  |
L | | FI | | | Granisetron Fresenius i.v. 1mg/1ml | 5 Ampulle(n) | 28.94 | 47.90 | 10% | | Infusionskonzentrat: Granisetronum 1 mg/ml | Fresenius Kabi (Schweiz) AG | B / SL / SG | FB | | G |  |
L | | FI | | | Granisetron Fresenius i.v. 3mg/3ml | 5 Ampulle(n) | 66.67 | 88.90 | 10% | | Infusionskonzentrat: Granisetronum 3mg / 3ml | Fresenius Kabi (Schweiz) AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Kytril 1 mg | 2 Tablette(n) | 11.52 | 28.95 | 10% | | Filmtabletten: Granisetronum 1 mg | Atnahs Pharma Switzerland AG | B / SL | FB | | G |  |
L | | FI | PI | | Kytril 2 mg | Tablette(n) | 11.52 | 28.95 | 10% | | Filmtabletten: Granisetronum 2 mg | Atnahs Pharma Switzerland AG | B / SL | FB | | G |  |
| | FI | PI | | Kytril 1 mg | 10 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Granisetronum 1 mg | Atnahs Pharma Switzerland AG | B | FB | | G |  |
| | FI | PI | | Kytril 2 mg | 5 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Granisetronum 2 mg | Atnahs Pharma Switzerland AG | B | FB | | G |  |
| | FI | | | Granisetron Labatec 1mg/ml | Ampulle(n) | PA | PA | k.A. | | | Labatec Pharma SA | B | FB | | G |  |
| | FI | | | Granisetron Labatec 1mg/ml | 5 Ampulle(n) | PA | PA | k.A. | | | Labatec Pharma SA | B | FB | | G |  |
| | FI | | | Granisetron Labatec 3mg/3ml | Ampulle(n) | PA | PA | k.A. | | | Labatec Pharma SA | B | FB | | G |  |
| | FI | | | Granisetron Labatec 3mg/3ml | 5 Ampulle(n) | PA | PA | k.A. | | | Labatec Pharma SA | B | FB | | G |  |
| | | | | Kytril | Fertigspritze(n) | PA | PA | k.A. | | Infusionskonzentrat: 2 Wirkstoffe | Roche Pharma (Schweiz) AG | B | FB | | G |  |
|
L | KFI | FI | | | Aloxi | Durchstechflasche(n) | 47.97 | 68.15 | 10% | | Injektionslösung: Palonosetronum | Medius AG | B / SL / SO | FB | | G |  |
L | | FI | | | Palonosetron Accord 0,25 mg/5 ml | | 40.77 | 60.75 | 10% | | Injektionslösung: Palonosetronum | Accord Healthcare AG | ● B / SL / SG | FB | | G |  |
L | | FI | | | Palonosetron-Teva 0.25 mg/5 ml | | 40.77 | 60.75 | 10% | | Injektionslösung: Palonosetronum | Teva Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | | | Palonosetron Labatec 0.25 mg/ 5 ml | | 40.77 | 60.75 | 10% | | solution injectable i.v.: Palonosetronum | Labatec Pharma SA | B / SL / SG | FB | | G |  |
L | | FI | PI | | Aloxi 500 Mikrogramm | Kapsel(n) | 62.47 | 84.35 | 10% | | capsule molle: Palonosetronum 500 µg | Medius AG | B / SL | FB | | G |  |
|
L | | FI | | | Akynzeo IV 235 mg / 0.25 mg | | 77.72 | 100.95 | 10% | | Infusionskonzentrat: 2 Wirkstoffe | Medius AG | B / SL | FB | | G |  |
L | | FI | PI | | Akynzeo 300 mg/0.5 mg | Kapsel(n) | 81.24 | 104.75 | 10% | | Kapseln: 2 Wirkstoffe | Medius AG | B / SL | FB | | G |  |
|
L | KFI | FI | | | Ivemend 150 mg | Durchstechflasche(n) | 58.24 | 79.75 | 10% | | Infusionspräparat: Fosaprepitantum 150 mg | MSD Merck Sharp & Dohme AG | B / SL | FB | | G |  |
L | KFI | FI | PI | | Emend 125 mg | 3 Kapsel(n) | 55.53 | 76.80 | 10% | | Kapseln: Aprepitantum 125 mg | MSD Merck Sharp & Dohme AG | B / SL | FB | | G |  |
| KFI | FI | PI | | Emend 80 mg - T | 2 Kapsel(n) | PA | PA | k.A. | | Kapseln: Aprepitantum 80 mg | MSD Merck Sharp & Dohme AG | B | FB | | G |  |
|
| | | PI | Ph | Zintona | 10 | PA | PA | k.A. | | Kapseln: Zingiberis Rhizomatis Pulvis 250 mg | Chrisana GmbH | D | FB | | G |  |
| | | PI | Ph | Zintona | 20 | PA | PA | k.A. | | Kapseln: Zingiberis Rhizomatis Pulvis 250 mg | Chrisana GmbH | D | FB | | G |  |
|
| | | PI | H | Similasan Reisekrankheit | 4.5 g | PA | PA | k.A. | | Globuli: 4 Wirkstoffe | Similasan AG | D | FB | | G |  |
| | | PI | H | Similasan Reisekrankheit | 15 g | PA | PA | k.A. | | Globuli: 4 Wirkstoffe | Similasan AG | D | FB | | G |  |
| | | PI | H | Cocculine | 30 Tablette(n) | PA | 12.30 | k.A. | | Tabletten: 4 Wirkstoffe | Boiron SA | D | FB | | G |  |
| | | PI | H | Similasan Reise- Beschwerden N | 60 | PA | PA | k.A. | | Tabletten: 4 Wirkstoffe | Similasan AG | D | FB | | G |  |
| | | PI | H | Similasan Reisekrankheit | 60 | PA | PA | k.A. | | Tabletten: 4 Wirkstoffe | Similasan AG | D | FB | | G |  |
| | | PI | H | Dr. Reckeweg R 52 Vomisan | 50 ml | PA | PA | k.A. | | gouttes buvables: 8 Wirkstoffe | Laboratoire Jacques Reboh et fils SA | D | FB | | G |  |